These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11013361)
1. Avascular necrosis of the femoral head in chronic myeloid leukemia patients treated with interferon-alpha: a synergistic correlation? Kozuch P; Talpaz M; Faderl S; O'Brien S; Freireich EJ; Kantarjian H Cancer; 2000 Oct; 89(7):1482-9. PubMed ID: 11013361 [TBL] [Abstract][Full Text] [Related]
2. Avascular necrosis in patients with chronic myeloid leukemia: A systematic review. Yassin M; Al-Mashdali AF; Al-Dubai HN Acta Biomed; 2022 Mar; 93(1):e2022017. PubMed ID: 35315390 [TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature. Bremer CT; Lastrapes A; Alper AB; Mudad R Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597 [TBL] [Abstract][Full Text] [Related]
4. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272 [TBL] [Abstract][Full Text] [Related]
5. A case of avascular necrosis of the femoral head as initial presentation of chronic myelogenous leukemia. Moon JY; Kim BS; Yun HR; Choi JH; Lee YY; Kim IS; Ahn MJ Korean J Intern Med; 2005 Sep; 20(3):255-9. PubMed ID: 16295787 [TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia presenting with avascular necrosis of femur head. Gupta D; Gaiha M; Siddaraju N; Daga MK; Anuradha S J Assoc Physicians India; 2003 Feb; 51():214-5. PubMed ID: 12725271 [TBL] [Abstract][Full Text] [Related]
7. Avascular necrosis of femoral head as the initial manifestation of CML. Kumar S; Bansal D; Prakash M; Sharma P Pediatr Hematol Oncol; 2014 Sep; 31(6):568-73. PubMed ID: 24087840 [TBL] [Abstract][Full Text] [Related]
9. Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report. Ozet A; Ozet G; Calişkaner Z; Kömürcü S; Oztürk B Endocr J; 1997 Oct; 44(5):715-7. PubMed ID: 9466328 [TBL] [Abstract][Full Text] [Related]
11. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa]. Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia. Chim CS; Ma SK; Lam CK Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520 [TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients. Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644 [TBL] [Abstract][Full Text] [Related]
14. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization]. Song YQ; Li W; Kong LH; Wang GJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287 [TBL] [Abstract][Full Text] [Related]
15. The role of interferon-alpha in the treatment of chronic myeloid leukemia. Kujawski LA; Talpaz M Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986 [TBL] [Abstract][Full Text] [Related]
16. Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia. Tóthová E; Fricová M; Kafková A; Stecová N; Guman T; Raffac S; Hlebasková M Neoplasma; 2000; 47(2):125-8. PubMed ID: 10985480 [TBL] [Abstract][Full Text] [Related]
17. Targeted chronic myeloid leukemia therapy: Seeking a cure. Fausel C Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932 [TBL] [Abstract][Full Text] [Related]
18. Avascular necrosis of the femoral head following trochanteric fractures in adults: a systematic review. Barquet A; Mayora G; Guimaraes JM; Suárez R; Giannoudis PV Injury; 2014 Dec; 45(12):1848-58. PubMed ID: 25467713 [TBL] [Abstract][Full Text] [Related]
19. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic myeloid leukemia with interferon-alpha]. Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]